| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Inmed Pharmaceuticals Inc. (INM) has 10 insiders with recent SEC Form 4 filings, including 3 buys and 0 sells. INM is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 72.5K | $108.1K | +193.0K | |
| CEO | 49.0K | $73.1K | - | |
| COO | 25.4K | $37.9K | - | |
| CFO | 24.3K | $36.1K | - | |
| VP | 18.3K | $27.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 29, 2021 | Adams Eric A | President &CEO | Buy | 8,800 | $1.73 | $15,224.00 | +32.0% | -25.8% | -87.4% | |
| Sep 28, 2021 | Adams Eric A | President &CEO | Buy | 11,400 | $1.75 | $19,984.20 | +70.9% | -22.5% | -87.2% | |
| Sep 28, 2021 | Colwill Bruce | CFO | Buy | 5,000 | $1.77 | $8,840.00 | +330.0% | -22.5% | -87.2% |